Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981747891> ?p ?o ?g. }
- W2981747891 abstract "The increasing burden and the continued suboptimal outcomes for patients with heart failure underlines the importance of continued research to develop novel therapeutics for this disorder. This can only be accomplished with successful translation of basic science discoveries into direct human application through effective clinical trial design and execution that results in a substantially improved clinical course and outcomes. In this respect, phase II clinical trials play a pivotal role in determining which of the multitude of potential basic science discoveries should move to the large and expansive registration trials in humans. A critical examination of the phase II trials in heart failure reveals multiple shortcomings in their concept, design, execution, and interpretation. To further a dialogue on the challenges and potential for improvement and the role of phase II trials in patients with heart failure, the Food and Drug Administration facilitated a meeting on October 17, 2016, represented by clinicians, researchers, industry members, and regulators. This document summarizes the discussion from this meeting and provides key recommendations for future directions." @default.
- W2981747891 created "2019-11-01" @default.
- W2981747891 creator A5001281862 @default.
- W2981747891 creator A5005476313 @default.
- W2981747891 creator A5010033834 @default.
- W2981747891 creator A5011293667 @default.
- W2981747891 creator A5012106161 @default.
- W2981747891 creator A5015881279 @default.
- W2981747891 creator A5017097200 @default.
- W2981747891 creator A5017812205 @default.
- W2981747891 creator A5018935225 @default.
- W2981747891 creator A5019352600 @default.
- W2981747891 creator A5022305626 @default.
- W2981747891 creator A5024221071 @default.
- W2981747891 creator A5029772859 @default.
- W2981747891 creator A5030231894 @default.
- W2981747891 creator A5034586607 @default.
- W2981747891 creator A5037425074 @default.
- W2981747891 creator A5039300626 @default.
- W2981747891 creator A5039800294 @default.
- W2981747891 creator A5044234611 @default.
- W2981747891 creator A5047716997 @default.
- W2981747891 creator A5050899070 @default.
- W2981747891 creator A5051997419 @default.
- W2981747891 creator A5053760015 @default.
- W2981747891 creator A5054890754 @default.
- W2981747891 creator A5056249145 @default.
- W2981747891 creator A5063362950 @default.
- W2981747891 creator A5064253025 @default.
- W2981747891 creator A5070514003 @default.
- W2981747891 creator A5073988431 @default.
- W2981747891 creator A5074102777 @default.
- W2981747891 creator A5079420772 @default.
- W2981747891 creator A5080222829 @default.
- W2981747891 creator A5085252887 @default.
- W2981747891 creator A5086287347 @default.
- W2981747891 creator A5086409547 @default.
- W2981747891 creator A5086797931 @default.
- W2981747891 creator A5087458309 @default.
- W2981747891 creator A5089810066 @default.
- W2981747891 creator A5091291156 @default.
- W2981747891 creator A5091868441 @default.
- W2981747891 date "2017-04-01" @default.
- W2981747891 modified "2023-10-18" @default.
- W2981747891 title "Reassessing Phase II Heart Failure Clinical Trials" @default.
- W2981747891 cites W1646382336 @default.
- W2981747891 cites W1858100092 @default.
- W2981747891 cites W1883738259 @default.
- W2981747891 cites W1978284123 @default.
- W2981747891 cites W2025395993 @default.
- W2981747891 cites W2033980725 @default.
- W2981747891 cites W2054183115 @default.
- W2981747891 cites W2054965274 @default.
- W2981747891 cites W2057956109 @default.
- W2981747891 cites W2058542276 @default.
- W2981747891 cites W2068519950 @default.
- W2981747891 cites W2069722675 @default.
- W2981747891 cites W2071907783 @default.
- W2981747891 cites W2101551652 @default.
- W2981747891 cites W2124301281 @default.
- W2981747891 cites W2126770408 @default.
- W2981747891 cites W2130114357 @default.
- W2981747891 cites W2130483595 @default.
- W2981747891 cites W2138839431 @default.
- W2981747891 cites W2142768873 @default.
- W2981747891 cites W2143094666 @default.
- W2981747891 cites W2143619265 @default.
- W2981747891 cites W2152072062 @default.
- W2981747891 cites W2157204705 @default.
- W2981747891 cites W2158510636 @default.
- W2981747891 cites W2168017932 @default.
- W2981747891 cites W2168507847 @default.
- W2981747891 cites W2169560588 @default.
- W2981747891 cites W2196906371 @default.
- W2981747891 cites W2198137225 @default.
- W2981747891 cites W2288457759 @default.
- W2981747891 cites W2297790284 @default.
- W2981747891 cites W2335312575 @default.
- W2981747891 cites W2535547710 @default.
- W2981747891 cites W2546982088 @default.
- W2981747891 cites W2555012562 @default.
- W2981747891 cites W59066530 @default.
- W2981747891 cites W86846889 @default.
- W2981747891 cites W2067484683 @default.
- W2981747891 doi "https://doi.org/10.1161/circheartfailure.116.003800" @default.
- W2981747891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5400283" @default.
- W2981747891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28356300" @default.
- W2981747891 hasPublicationYear "2017" @default.
- W2981747891 type Work @default.
- W2981747891 sameAs 2981747891 @default.
- W2981747891 citedByCount "13" @default.
- W2981747891 countsByYear W29817478912017 @default.
- W2981747891 countsByYear W29817478912018 @default.
- W2981747891 countsByYear W29817478912019 @default.
- W2981747891 countsByYear W29817478912021 @default.
- W2981747891 countsByYear W29817478912022 @default.
- W2981747891 countsByYear W29817478912023 @default.
- W2981747891 crossrefType "journal-article" @default.
- W2981747891 hasAuthorship W2981747891A5001281862 @default.
- W2981747891 hasAuthorship W2981747891A5005476313 @default.